Notice Concerning the Establishment of an AI Development Office | Convano Inc. (6574) timely disclosure

Worth reading

23Immaterial

0–100. This measures how worthwhile something is to read, not how good or bad the company is.

Direction

Improvement

Direction inferred from the company’s description.

Scale

—

Displayed only when the document provides numerical figures.

Wording

Definitive

How definitive the wording is.

Who is moving to which position

Details of organizational changes

The Company established an AI Development Office as an in-house organization. The office is responsible for AXON's planning and development, functionality development, and implementation support for healthcare institutions. The office was established on 1 September 2026.

Who is moving to which position
Item	Details
Details of organizational changes	The Company established an AI Development Office as an in-house organization. The office is responsible for AXON's planning and development, functionality development, and implementation support for healthcare institutions. The office was established on 1 September 2026.

Items this document does not state (20)

Resolution dateScheduled Appointment DateDate of departureName of appointeeAppointee's new positionAppointee's previous positionAppointee's date of birthYear the appointee joined the CompanyNumber of shares held by the appointeeName of departing officerFormer position of departing officerNew position of departing officerReason for departureWhether the incumbent will remain in officeReason for changeReasons for appointmentNumber of directors after the changeFiling as an independent officerChange in Corporate Governance StructureSubject to Approval by the General Meeting of Shareholders

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The office was established to create a structure for specialized efforts to continuously expand AXON's functionality and support its implementation by healthcare institutions. At the AI Development Office, physicians will participate in planning and development, including the development of functions that support the drafting of medical records and the verification of medical reimbursement calculations.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.

Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.

Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.